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Abstract
Background The coverage of the atelocollagen membrane
at the chondral defect after subchondral drilling might
improve the beneficial effects for cartilage repair because of
the prevention of scattering and accumulation of cells and
growth factors from bone marrow within the chondral
defect. On the other hand, it might block cells and factors
derived from the synovium or cause high pressure in the
chondral defect, resulting in prevention of cells and growth
factors gushing out from the bone marrow, which leads to
disadvantages for cartilage repair.
Method We tested this hypothesis in a 2-mm-diameter
chondral defect created in the articular cartilage of the
patellar groove in a rat models. Defects were left untreated,
or were drilled or drilled and covered with an atelocollagen
membrane; healing was evaluated by histology and gene
expression analysis using real-time polymerase chain
reaction and immunohistochemistry.
Results Membrane coverage induced bone tissue
ingrowth into the punched chondral defect. At 1 week,
expression of TGFb, Sox9, Runx2, osteocalcin, Col1a1,
and Col2a1 in the drilling group was significantly higher
than in the covering group. At 4 weeks, expressions of
TGFb, Runx2, and Col1a1 were all significantly higher in
the drilling group, while Sox9, osteocalcin, and Col2a1
were significantly higher in the covering group. Immu-
nohistochemistry demonstrated Sox9, osteocalcin, and
type II collagen on the bony reparative tissue in the
covering group.
Conclusions These results suggest that the atelocollagen
membrane coverage resulted in inhibition of cartilage
repair.
Introduction
Articular cartilage has very limited healing potential,
because it lacks a blood supply and is isolated from sys-
temic regulation [1]. The most widely practiced methods of
repairing defects are bone marrow stimulation techniques
such as subchondral drilling, abrasion, and microfracture,
procedures that aim to recruit bone marrow elements to
repair cartilage defects [2–7]. Such procedures are thought
to promote chondrogenesis, inducing formation of fibrous
tissue, fibrocartilage, and/or hyaline cartilage by inducing
migration of bone marrow mesenchymal stromal cells
(MSCs) from the subchondral bone by bleeding. However,
in experimental studies these techniques have resulted in
the formation of fibrocartilaginous tissues [3, 7, 8]. There
are several possible reasons why bone marrow-stimulating
procedures do not always induce satisfactory results. One
explanation is that the number of bone marrow MSCs may
not be adequate to repair the lesion. Nishimori et al. [9]
demonstrated that the addition of cultured bone marrow
MSCs to a defect in combination with a bone marrow-
stimulating procedure accelerated regeneration of articular
cartilage in the defects better than the bone marrow-stim-
ulating procedure alone.
One suggested reason why the number of bone marrow
MSCs may be inadequate to repair the lesion could be that
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they diffuse into the joint fluid and do not remain in the
chondral defect. Therefore, we estimated that the use of an
atelocollagen membrane to cover a chondral defect after
subchondral drilling exerts beneficial effects on cartilage
repair by preventing scattering of cells and growth factors
from the bone marrow and causing them to accumulate
within the chondral defect. The purpose of this study was to
examine the effect and the mechanism of atelocollagen
membrane coverage combined with subchondral drilling
on cartilage regeneration.
Materials and methods
Animal preparation
All procedures were performed in accordance with the
Guide for Animal Experimentation, Hiroshima University,
and the Committee of Research Facilities for Laboratory
Animal Sciences, Graduate School of Biomedical Sci-
ences, Hiroshima University (no. A10-97).
Male Sprague–Dawley rats (12 weeks old) were used in
this study. A total of 50 knees of 26 rats were used. Before
surgery, the animals were anesthetized with an intraperi-
toneal injection of 1 ml/kg pentobarbital sodium. The
patella was everted through a medial approach. A chondral
defect of 2 mm diameter was created in the articular car-
tilage of the patellar groove of the distal femur using a
biopsy punch. The control group represented the natural
course of healing of the chondral defect. In the drilling
group, five holes were drilled into the cartilage using a 0.2-
mm-diameter drill. In the covering group, we applied
instant glue approved for clinical application (Aron Alpha
A ‘‘Sankyo,’’ Daiichi Sankyo, Tokyo, Japan), containing a-
cyanoacrylate monomer, around the drilled defect and
covered it with a recombinant peptide membrane (Fujifilm,
Tokyo, Japan), which has low ecotoxicology and high
uniformity, created using a yeast culture technique. The
membrane was a rectangle of 4 9 5 mm and 5 lm thick-
ness. No bleeding was observed in the untreated chondral
defects, while bleeding derived from the bone marrow
could be observed in chondral defects treated by drilling.
In the drilling and covering group, blood clots or
reparative tissue in the defect were extracted and analyzed
for expression of several factors as markers of chondro-
genesis and osteogenesis, and extracellular matrix was
analyzed by real-time polymerase chain reaction (PCR) at
1 and 4 weeks after creation of the defects. At 4 weeks
after creation of the defects, the rats were euthanized by
intraperitoneal injection of a lethal dose of pentobarbital
sodium. The distal femora were resected en bloc and fixed
in 4 % paraformaldehyde for 24 h at 4 C. They were then
decalcified in 0.5 M EDTA, then embedded in paraffin and
cut into 5-lm sections serially along the sagittal plane that
included the center of the defect, and histological evalua-
tion was performed.
Quantitative reverse transcription polymerase chain
reaction (real-time PCR)
To examine the expression of chondrogenic and osteogenic
marker genes such as Col2a1, Sox9, TGFb, Col1a1, Runx2,
and osteocalcin, real-time PCR was performed using
SYBR Green (Invitrogen, Carlsbad, CA, USA). Total RNA
was isolated from blood clots or reparative tissue that had
been homogenized on ice with Trizol reagent (Invitrogen).
One lg of total RNA was reverse-transcribed using the
QuantiTect Reverse Transcription Kit (Qiagen, Chats-
worth, CA, USA) according to the manufacturer’s protocol.
Real-time PCR was performed using a Real-time PCR
System (Applied Biosystems, Carlsbad, CA) in a 20-ll
PCR mixture containing 1.0-ll template cDNA, 10 ll
SYBR Green mix, 1.5 lM primer, and water to adjust the
final volume to 20 ll. Primer sequences are listed in
Table 1.
All reactions were performed in triplicate in a 96-well
plate and incubated at 95 C for 10 min, followed by 40
cycles of 95 C for 15 s and 60 C for 1 min. The GAPDH
gene was used as a control to normalize differences in total
RNA levels between samples. A threshold cycle (CT) was
observed in the exponential phase of amplification, and
quantification of relative expression levels was performed
using standard curves for target genes and the endogenous
control. Geometric means were used to calculate the DDCT
Table 1 Primer sequences used for real time polymerase chain reaction (PCR)
Target genes Primer sequence forward Primer sequence reverse
TGF-b 50-TATAGCAACAATTCGTGGCG-30 50-CAGAAGTTGGCATGGTAGCC-30
Sox9 5-CGTCAACGGCTCCAGCA-30 50-TGCGCCCACACCATGA-30
Runx2 50-CACCCTCAAGAGCCTGAGTC-30 50-CAGACGGCTGAGTAGGGAAC-30
Osteocalcin 5-GCATTCTGCCTCTCTGACCT-30 50-CTAAACGGTGGTGCCATAGA-30
Col1a1 50-TGCCGTGACCTCAAGATGT-30 5-TGGGGI 1 IGGGCTGATGTA-30
Col2a1 50-CCCAGAACATCACCTACCAC-30 50-GGTACTCGATGATGGTCTTG-30
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(delta–delta CT) values and expressed as 2
-DDCT. The
value of each control sample was set at 1 and used to
calculate the fold change of target genes.
Histological evaluation
For histological evaluation of cartilage regeneration, sec-
tions were stained with safranin-O/fast green. The speci-
mens were graded semi-quantitatively by two observers
who were not aware of the source of cartilage. The grading
scale was based on filling of the defect (0–4 points), any
reconstitution of the osteochondral junction (0–2 points),
matrix staining (0–4 points), and cell morphology (0–4
points) as described by Pineda et al. [10] (Table 2).
For immunohistological evaluation, sections were
mounted onto poly-L-lysine-coated glass slides and
immersed in 0.3 % H2O2 to block endogenous peroxidase
activity. The sections were blocked with normal goat serum
and then incubated with mouse monoclonal antibodies
directed against type II collagen and Runx2, and rabbit
monoclonal antibodies directed against TGF-b, Sox9,
osteocalcin, and type I collagen (Fuji Chemipha, Toyama,
Japan). The reaction for visualization was performed using
an avidin-biotin peroxidase system (Vectastain Elite ABC
kit; Vector Laboratories, Burlingame, CA, USA), and color
was developed with a freshly prepared diaminobenzidine
solution.
Statistical analysis
One-way analysis of variance (ANOVA) followed by Tu-
key’s post hoc analysis was used to compare Pineda’s
scales among the three groups. The Mann-Whitney U test
was used to compare gene expression between two groups.
P values less than 0.05 were considered to be statistically
significant. All statistical analyses were performed on a
personal computer using the Stat View statistical package
version 5.0(Abacus Concepts, Berkeley, CA, USA).
Results
Gross appearance
At 1 week, blood clots were present in the chondral defects
of both the drilling and the covering groups, while the
cartilage defect in the control group appeared to be empty.
In the covering group, the atelocollagen membrane cov-
ering the chondral defect still remained (Fig. 1a–c). At
4 weeks, all models showed ingrowth of reparative tissue
into the defects (Fig. 1d–f). In the control group, the defect
margins were clearly recognizable. The defect was filled
with fibrous tissue, and its surface was rough and depressed
(Fig. 1d). In the drilling group, the margins of the cartilage
defects were also clearly recognizable, and the defect
surface was depressed; however, reparative tissue filling
the defect was smooth, with an appearance like the normal
surface of joint cartilage (Fig. 1e). In the covering group,
the defect margins were uneven, and bony spurs were
observed in the defect. The surface of the cartilage around
the defect showed osteoarthritic changes with degeneration
of cartilage and spur formation (Fig. 1f).
Histological evaluation
In the control group, no staining with safranin O was
observed in the chondral defect area; instead fibrous tissue
filled the chondral defect (Fig. 2a). The histological score
of all the control samples was 11 points. In the drilling
group, the margins of the defect were clearly recognizable
and ingrowth of hyaline cartilage could be observed in the
deep layer of fibrous tissue in the defect (Fig. 2b). The
mean histological score was 6.2 ± 0.6 points. In the cov-
ering group, the margins of the defect were irregular
because of bone formation. Virtually no hyaline cartilage
Table 2 Histologic grading of the osteochondral defects (Pineda
et al. [11])
Category Points
Cell morphology
Hyaline cartilage 0
Mostly hyaline cartilage 1
Mostly fibrocartilage 2
Mostly non-cartilage 3
Non-cartilage only 4
Matrix staining (metachromasia)
Normal (compared with host adjacent cartilage) 0
Slightly reduced 1
Markedly reduced 2
No metachromatic stain 3
Surface regularity
Smooth ([3/4) 0
Moderate ([1/2–3/4) 1
Irregular (1/4–1/2) 2
Severely irregular (\1/4) 3
Thickness of cartilage
[2/3 0
1/3–2/3 1
\1/3 2
Integration of donor with host adjacent cartilage
Both edge integrated 0
One edge integrated 1
Neither edge integrated 2
Total maximum 14
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was observed in the margins of the defect, while in the
chondral defect area, abundant bone tissue was observed
(Fig. 2c). The mean histological score was 12.7 ± 0.6
points. The histological score in the drilling group was
therefore significantly better than in the other two groups.
In contrast, the histological score in the covering group was
significantly worse than that in the other two groups
(Table 3).
Gene expression analysis
At 1 week, real-time PCR analysis revealed that expres-
sions of TGFb, Sox9, Runx2, osteocalcin, Col1a1, and
Col2a1 in the drilling group were all significantly higher
than in the covering group (Fig. 3). At 4 weeks, the
expressions of TGFb, Runx2, and Col1a1 were significantly
higher in the drilling group, while the expressions of Sox9,
osteocalcin, and Col2a1 were significantly higher in the
covering group (Fig. 4).
Immunohistological assessments
Immunohistochemistry at 4 weeks after creation of the
defects showed positive immunoreactivity of TGFb in the
deep layer of fibrous reparative tissue above the area of
ingrowth of hyaline cartilage stained with safranin O/fast
green in the drilling group (Figs. 2b, 5b), but no positive
immunoreactivity in the covering group (Fig. 5c). How-
ever, Sox9-immunopositive cells were observed in the area
of hyaline cartilage ingrowth in the safranin O/fast green-
stained area in the drilling group (Fig. 2b, 5e) and the bony
reparative tissue in the covering group (Fig. 5f). Runx2-
Fig. 1 Representative pictures of chondral defects at 1 week and
4 weeks after the creation of models. a Control group (1 week)
represents the natural course of healing of the chondral defect.
b Drilling group (1 week); five holes were drilled into the chondral
defect using a 0.2-mm-diameter drill. c Covering group (1 week);
instant glue suitable for clinical use was applied around the drilled
defect, and a recombinant peptide membrane was used to cover it.
d Control group (4 weeks); ingrowth of fibrous tissue was observed.
No cartilage was observed growing into the margins of the defect.
e Drilling group (4 weeks); ingrowth of hyaline cartilage could be
observed in a deep layer of fibrous tissue. f Covering group; ingrowth
of bony tissue was observed, while no growth of hyaline cartilage into
the margins of the defect could be seen
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immunopositive cells were observed in the safranin O/fast
green-stained area of hyaline cartilage ingrowth in the
drilling group (Figs. 2b, 5h) and in the shallow layer of
reparative tissue in the covering group (Fig. 5i). Positive
staining for osteocalcin was observed in all areas of
reparative tissue in the covering group. In the drilling
group, the area of hyaline cartilage showed immunoreac-
tivity for osteocalcin (Figs. 2b, 5k). Particularly strong
osteocalcin staining was observed in bony reparative tissue
in the covering group (Fig. 5l). Positive immunoreactivity
for type I collagen was observed on the fibrous reparative
tissue in the drilling group (Fig. 5n) and in the shallow
fibrous reparative tissue in the covering group (Fig. 5o),
while positive immunoreactivity for type II collagen was
observed in the area of safranin O/fast green-stained hya-
line cartilage ingrowth in the drilling group (Figs. 2b, 5q)
and in the bony reparative tissue in the covering group
(Fig. 5r).
These results are summarized in Table 3.
Discussion
We had expected that atelocollagen membrane coverage of
the drilled chondral defect might exert beneficial effects on
cartilage repair because of the accumulation of cells and
Fig. 2 Safranin O/fast green staining of chondral defect sections at
4 weeks after the creation of models. a Control group; ingrowth of
fibrous tissue could be seen. No cartilage was observed growing into
the margins of the defect. b Drilling group; ingrowth of hyaline
cartilage could be observed in the deep layer of fibrous tissue.
c Covering group; there was ingrowth of bony tissue into the defect,
but no growth of hyaline cartilage could be observed. Focus; 940
Table 3 Summary of gross appearance, PCR analysis, histological, and immunohistochemical results
Control (n = 5) Drilling (n = 5) Covering (n = 5)
Gross appearance at 4 weeks Rough and depressed Smooth Uneven, bony spur
Pineda’s score 11 ± 0* 6.2 ± 0.6* 12.7 ± 0.6*
Real time PCR 1 week 4 weeks 1 week 4 weeks
TGFb 1.9 ± 0.4* 1.2 ± 0.4* 1.2 ± 0.6* 0.4 ± 0.3*
Sox9 9.7 ± 9.3* 0.7 ± 0.3* 1.6 ± 0.9* 0.4 ± 0.2*
RUNX2 1.5 ? 0.9* 1.1 ± 1.3* 0.6 ± 0.3* 0.7 ± 0.4*
Osteocalcin 6.1 ± 6.0* 1.1 ± 0.3* 0.5 ± 0.4* 2.3 ± 0.4*
Collal 2.6 ± 1.6* 0.9 ± 0.2* 1.9 ± 0.6* 0.3 ± 0.2*
Col2al 2.9 ± 3.3* 1.0 ± 0.2* 1.4 ? 1.7* 2.2 ± 0.5*
Immunohistological results
The distribution of positive immunoreactivity
TGFb No immunoreactivity Deep layer of fibrous reparative tissue above
the area of ingrowth of hyaline cartilage
No immunoreactivity
Sox9 Deep layer of reparative tissue Area of hyaline cartilage ingrowth Bony reparative tissue
Runx2 No immunoreactivity Area of hyaline cartilage ingrowth Shallow layer of reparative
tissue
Osteocalcin Shallow layer of reparative tissue Area of hyaline cartilage ingrowth All area of reparative tissue
Collal No immunoreactivity Fibrous reparative tissue Shallow fibrous reparative
tissue
Col2al No immunoreactivity Area of hyaline cartilage ingrowth Bony reparative tissue
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growth factors derived from bone marrow in the chondral
defect. However, in contrast to our expectations, the find-
ings of this study demonstrate that covering the chondral
defect induced the ingrowth of bone-like tissue instead of
cartilage regeneration in the chondral defect area.
At 1 week after creation of the defects, the mRNA
expression levels of TGF-b, Sox9, Runx2, osteocalcin,
Col2a1, and Col1a1 in the covering group were
significantly lower than in the drilling group. The expres-
sion pattern of these factors might contribute to poor
chondral repair caused by coverage of the chondral defect.
On the other hand, the mRNA expression levels of osteo-
calcin were significantly higher in the covering group at
4 weeks after creation of the defect. Osteocalcin promotes
the differentiation and function of osteoblasts and matu-
ration of bone cells [11]. Therefore, the high mRNA
Fig. 3 Real-time PCR analysis
at 1 week after creation of the
defects. The expressions of
TGFb, SOX9, RUNX2,
osteocalcin, Col1a1, and Col2a1
were significantly higher in the
drilling group (P \ 0.05)
Fig. 4 Real-time PCR at
4 weeks after creation of the
defects. The expressions of
TGFb, SOX9, RUNX2, and
Col1a1 were significantly
higher in the drilling group.
Conversely, the expressions of
osteocalcin and Col2a1 were
significantly higher in the
covering group (P \ 0.05)
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expression of osteocalcin and its positive immunoreactivity
on the bony reparative tissue in the covering group suggest
that coverage of the cartilage defect induced the growth of
bony tissue into the chondral defect. Expressions of both
TGF-b and Runx2 were suppressed in the chondral defect
covered with atelocollagen membrane both at 1 week and
4 weeks. TGF-b inhibits differentiation of osteoblasts by
inhibiting the function of Runx2 [12–14] and promotes the
proliferation of chondrocytes through the MEK-ERK-Elk1
signaling pathway [15, 16]. Runx2 promotes the differen-
tiation of immature chondrocytes into mature chondrocytes
and meanwhile inhibits differentiation of immature osteo-
blasts into mature osteoblasts [17, 18]. Therefore, low
levels of TGF-b and Runx2 might be disadvantageous for
chondrogenesis in the cartilage repair process.
The technique of subchondral drilling promotes chon-
drogenesis with the formation of fibrous tissue, fibrocarti-
lage, and/or hyaline cartilage by inducing the influx of bone
marrow mesenchymal stromal cells from the subchondral
bone by bleeding. However, in previous experimental
studies this method has been shown to result in the forma-
tion of fibrocartilage with no formation of hyaline cartilage
[3, 6, 7]. Mienaltowski et al. [19] created a chondral defect
and performed microfracture of the subchondral bone in the
medial femoral condyles of Quarter horses and compared
the expression of biomarkers in the reparative tissue with
that in normal cartilage using real-time PCR. They found
that the expression of Col1a1 was higher in the reparative
tissue, while the expressions of Col2a1 and Sox9 were
higher in normal cartilage. These results of reparative tissue
vs. normal cartilage are similar to our results comparing the
drilling group and the covering group, leading us to con-
clude that the pattern of expression of biomarkers is more
natural in the covering group.
There are several concerns associated with this study.
The first relates to the effect of the glue used in this study
on normal cartilage. The glue we used (Aron Alpha A) is
frequently used in the clinical setting. Several authors have
Fig. 5 Immunohistochemistry at 4 weeks after creation of the
defects. a, b, c TGF-b; no immunoreactivity was observed in the
reparative tissue in the control group. Positive immunoreactivity was
observed in the deep layer of fibrous reparative tissue above the area
of ingrowth of hyaline cartilage stained with safranin O/fast green in
the drilling group, and no immunoreactivity was observed in the
covering group. d, e, f Sox9; immunopositive cells were observed in
the deep layer of fibrous reparative tissue in the control group, on the
area of hyaline cartilage ingrowth in the drilling group, and in bony
reparative tissue in the covering group. g, h, i Runx2; no immuno-
positive cells in the reparative tissue were observed in the control
group. Immunopositive cells were observed in the area of hyaline
cartilage ingrowth in the drilling group and in the shallow layer of
reparative tissue in the covering group. j, k, l Osteocalcin; positive
immunoreactivities were observed in the shallow layer of reparative
tissue in the control group, in all areas of reparative tissue in both the
drilling and the covering groups. Especially strong staining was
observed in the bony reparative tissue in the covering group. m, n,
o Type I collagen; no immunoreactivity was observed in the
reparative tissue in the control group. Positive immunoreactivity
was observed in the fibrous reparative tissue in the drilling group and
in the shallow fibrous reparative tissue in the covering group. p, q,
r Type II collagen; no immunoreactivity was observed in the
reparative tissue in the control group. Positive immunoreactivity was
observed in the area of hyaline cartilage ingrowth in the drilling group
and in bony reparative tissue in the covering group. Focus, 940. Scale
bar; 200 lm
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demonstrated fixation of osteochondral fragments using
Aron Alpha A and reported that there were no foreign
matter reactions in the cartilage [20, 21]. We tried gluing
the recombinant peptide membrane to normal cartilage of
the distal femur using Aron Alpha A as a preliminary
experiment and concluded that it could be used safely for
this study. Second, there was the possibility of foreign
matter reactions caused by the membrane. Recombinant
peptide membranes are created using a yeast culture
technique and have low ecotoxicity. In the preliminary
experiment described above, there were no foreign matter
reactions, such as synovitis, and this suggested that
recombinant peptide membranes can be used safely in the
joint. Third, rat chondrocytes and human chondrocytes are
very different concerning structure and regenerative
potential. Therefore, the results of our study cannot be
applied directly to humans. Fourth, there was uncertainty
concerning how long the recombinant peptide membrane
was retained on the surface of the cartilage and played a
role in blocking cell migration. Therefore, we investigated
this by exposure of the knee in the covering group at 1, 2,
3, and 4 weeks after the operation. This showed that the
membrane was retained completely at 1 and 2 weeks.
However, breaks appeared in the membrane and it was only
partially retained, exposing the defect, at 3 weeks. At
4 weeks, the membrane had become completely detached
from the surface of the cartilage (data not shown). To
further confirm the integrity of the membrane, at 1 and
2 weeks, 1 ml of indigotindisulfonate sodium was injected
into the joint space, and this was then exposed 1 day after
injection to confirm whether the membrane was able to
block movement of the joint fluid. This investigation
showed that the defect was not stained at 1 or 2 weeks
(data not shown). According to these results, the recom-
binant peptide membrane was able to block movement of
joint fluid 2 weeks after the operation in our study.
In our study, the atelocollagen membrane blocked the
entry of cells and factors derived from the synovium. In
addition, this procedure caused high pressure in the chon-
dral defect and resulted in prevention of cells and growth
factors gushing out from bone marrow. These mechanisms
may have an inhibitory effect on cartilage repair. Christoph
et al. reported a beneficial effect of coverage of a micro-
fractured chondral defect using a cell-free polyglycolic
acid scaffold [22]. Thore et al. used a cell-free resorbable
polymer felt as the covering material and reported excellent
clinical results [23]. In these studies, however, the covering
materials acted as scaffolds for blood clot formation but did
not block the influx of joint fluid because of their felt-like
structure. The synovial fluid contains prolactin, and it
induces type II collagen and synthesis of proteoglycans
[24]. Furthermore, the synovial fluid contains TGFb, and
its concentration increases during the tissue repair process
[25]. In the present study, the synovial fluid was not able to
permeate the recombinant peptide-covering membrane, and
these factors were therefore unable to cause a beneficial
effect on chondrogenesis.
The recombinant peptide membrane exerted a blocking
effect for 2 weeks after creation of the cartilage defect;
consequently, synovial fluid might have influenced healing
of the defect thereafter. However, the directivity of tissue
regeneration is decided within 2 weeks of creation of the
cartilage defect [26]. Therefore, the factors derived from
synovial fluid couldn’t have a beneficial effect on cartilage
repair after 2 weeks. Furthermore, the stimulation of TGFb
promotes the expression of Sox9, and Sox9 promotes the
primary stage and inhibits the late stage of chondrocyte
differentiation [27, 28]. Therefore, we surmised that low
expression of Sox9 at 1 week, influenced by coverage,
caused inhibition of the primary stage of chondrocyte dif-
ferentiation, while high expression of Sox9 at 4 weeks,
induced by stimulation by TGFb contained in the synovial
fluid, caused inhibition of the late stage of chondrocyte
differentiation.
In order to benefit from such an effect on cartilage repair
by covering the chondral defect, it might be necessary to
use a membrane that allows permeation of cytokines
derived from the synovium.
In conclusion, coverage of chondral defects with atelo-
collagen after subchondral drilling inhibited cartilage
repair.
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